Pancreatic Cancer Treatment Market Size Worth $4.2 Billion By 2025

The global pancreatic cancer treatment market is expected to reach USD 4.2 billion in 2025, according to a new report by Grand View Research, Inc. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/pancreatic-cancer-treatment-market

Further key findings from the study suggest:

The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types
Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells
North America dominated the segment with the largest revenue share in 2015 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure
Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment
Some of the major companies operating in this market are, but are not limited to, Eli Lilly and Company; Celgene Corporation; F. Hoffmann-La Roche AG; Amgen, Inc.; Novartis AG; PharmaCyte Biotech, Inc.; Clovis Oncology; Teva Pharmaceutical Industries Ltd.; Merck & Co., Inc.; and Pfizer, Inc.

Waterborne Coatings Market Worth $82.9 Billion By 2025

The global waterborne coatings market is projected to reach USD 82.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is projected to expand at CAGR of 5.7% over the forecast period.

3d illustration. Blue paint splashing out of cans. Isolated white background

The prices of raw materials used in manufacturing waterborne coatings are expected to have a significant impact on the production cost of the final product. The demand for these raw materials from other application industries is expected to impact their availability for manufacturing waterborne coatings.

Increasing construction spending and requirement for improved infrastructure, particularly in Asia Pacific, is expected to drive waterborne coatings market over the forecast period. The share of construction spending is expected to shift from developed regions of North America and Europe to developing regions of Asia Pacific.

Increase in production capacities and launch of new automobile models is expected to remain a key driving factor for waterborne coatings market in automobile applications. Growing automotive industry in emerging markets of Asia Pacific, Central & South America, and the Middle East & Africa is expected to be another major factor driving waterborne coatings market.

Automotive OEM application segment is expected to grow at the highest rate over the forecast period. Increasing middle-class income level coupled with rising living standard in emerging economies of Asia Pacific and Central & South America is projected to fuel the automotive sales. Low-cost of production of waterborne coatings coupled with longer shelf life is expected to drive the demand for these coatings in this application segment.

Stringent government regulations to lower VOC content in paints & coatings is expected to drive the demand for waterborne coatings in the North American market. Countries in this region such as U.S., Canada and Mexico are witnessing an increase in government stimulus packages after the global economic recession that hit the region. Factors such as rising employment rates and improvement in consumer confidence are expected to drive North America waterborne coatings demand over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/waterborne-coatings-market

Further key findings from the report suggest:

In terms of volume, the global revenue for architectural application is anticipated to reach USD 21.70 billion by 2025, growing at a CAGR of 4.4% from 2018 to 2025
Acrylic resin dominated the market in terms of revenue, with a market share of over 83.07% in 2017 and is expected to continue its dominance over the forecast period.
Some of the key companies present in the market include AkzoNobel N.V., BASF SE, Axalta Coating Systems LLC, Berger Paints India Ltd.; Kansai Paint Co., Ltd; Nippon Paint Holdings Company Ltd; and PPG Industries, Inc. among various others players.

U.S. Air Freshener Market Size Worth $2.18 Billion By 2025

According to a recent report published by Grand View Research Inc.,wide-scale consumer awareness along with product modifications is set to fuelmarket expansion.

According to a report, “U.S. Air Fresheners Market Analysis by Product Type (Aerosol/Spray, Electric Air Fresheners, Gels, Candles, Others) by Application (Residential, Commercial, Cars, Others), Competitive Analysis And Segment Forecasts, 2018 – 2025”, published by Grand View Research, Inc. The U.S. air fresheners market was valued at USD 1.62 billion in 2016, registering a CAGR of 3.4%by 2025, as per a new report by Grand View Research Inc.Manufacturers are experimenting with new fragrances in order to pacify customer preferences in this market, and this trend is being adopted by the U.S consumers. Essential oil demand for several fragrances is at an all-time high presently, therefore hinting varied product diversification in this region.

The consumers are willing to pay a premium price for several aesthetic fragrances and this is encouraging air freshener companies to expand their product portfolio, thus, prompting growth in revenue in this region. The market is also driven by the consumer’s quest for their homes to smell good. In a recent survey conducted by the Census data and Simmons National Consumer Survey (NHCS), more than 80% of the U.S. population uses air freshener products, primarily for residential applications.

In 2017, the overall number of air freshener cans that have been sold were estimated to be more than 300 million, as more than 30 million U.S. residents have used 6 cans or more than in a year. These figures have showcased an excellent positive co-relation with disposable income indexes in the country.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/us-air-fresheners-market

U.S. Air Fresheners Market Highlights

The sprays/aerosolled product type segment in 2017. This product generated the maximum demand among consumers due to its excellent odor-neutralizing properties that are enhanced by the chemicals present in the aerosol/spray cans
The candles segmentis set to project healthy growth, on account of its aesthetic fragrance and is driven by the rising disposable income. This region’s disposable income is demonstrating stability after an initial downfall during the 2014 – 2016 period
The residential segment is the largest grossing segment and will be the fastest-growing of the U.S. air freshener market. The residential segment accounts for more than 70% of the revenue share
The car segment is projected to witness the second-largest growth over the forecast period. The U.S. car sales is optimistically growing and is expected to continue this trend by 2025after a marginal upset in 2018
The air freshener market is also expected to benefit from the booming trend of non-essential expenditure’s outpacing essential spending in this demographic. The commercial segment held a revenue of USD 223.4 million in 2017 and is anticipated to grow at a CAGR of 3.2% by 2025

Liver Disease Diagnostics Market Size Worth $48.7 Billion By 2027

The global liver disease diagnostics market size is expected to reach USD 48.7 billion by 2027, expanding at a CAGR of 6.5%, according to a new report by Grand View Research, Inc. increasing funding and research initiatives undertaken by market players is one of the major factors expected to propel market growth. For instance, in November 2019, Glycotest, Inc. received the second USD 3.0 million tranche of USD 10.0 million Series A funding from Shanghai Fosun Pharmaceutical Co., Ltd.(Fosun Pharma). Under this investment, Glycotest, Inc. transferred HCC panel technology to Fosun Pharma to commercialize in China and develop tests for liver cancer and liver fibrosis that are currently under pipeline.

Companies are focusing on collaborations and partnership to improve the quality of care,which is anticipated to drive the market. For instance, in October 2019, Perspectum Diagnostics entered into a partnership to offer LiverMultiScan at Precious Medical Center in Singapore. The aim of this partnership was to create awareness among people to consider liver checking as an integral part of their health screening.

Researchers conducting studies to support the development of novel diagnostic methods that can accurately differentiate between benign and malignant lesions are expected to fuel market growth. For instance, researchers from Charité – Universitätsmedizin Berlin used tomoelastography to visualize mechanical properties of tumors and developed a new Magnetic Resonance Imaging (MRI) technique to detect grading of tumor consistency.

Furthermore, companies are conducting clinical trials to develop new tests with high sensitivity and specificity. For instance, Laboratory for Advanced Medicine is conducting a clinical trial on 1,600 patients with liver cirrhosis using invasive biopsy through quantification of cfDNA methylation and comparing it with ultrasound technique. The test is projected to be completed in 2020.

Development and commercialization of accurate diagnostic methods is expected to boost the market. For instance, in March 2020, ENDRA Life Sciences Inc. received CE mark for TAEUS FLIP system. This system measures liver fat to identify and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). It is an ultrasound system that accurately and at point of care quantifies fat in the liver.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/liver-disease-diagnostics-market

Further key findings from the study suggest:

Imaging segment witnessed the largest market share in 2019 owing to increasing initiatives by key players to develop accurate imaging systems
Based on end-use, the hospitals segments held the largest share in 2019. Factors such as increasing adoption of advanced technologies and favorable reimbursement policies are expected to drive segment growth
North America dominated the market in 2019 due to increasing alcoholic consumption and rising awareness regarding chronic diseases
The market in Asia Pacific is projected to witness the fastest growth over the forecast period owing to the high unmet needs and rising regular check-ups for the diagnosis of diseases.

Smart Fitness Devices Market Size Worth $29.4 Billion By 2025

The global smart fitness devices market is expected to reach USD 29.4 billion by 2025, according to a new report by Grand View Research, Inc. The smart fitness devices market has witnessed a rising demand among the growing urban population in a bid to enhance their fitness goals. Advantages such as accessing fitness activities data in remote and real-time operations have resulted in an increased penetration of the market. Additionally, there are tremendous opportunities for advancements in the smart fitness devices owing to the increasing usage of smartphones and enhanced internet accessibility, which, in turn, would fuel the growth of smart fitness market. The growing adoption of the smart fitness devices to keep track of sleep, steps, calories, heart rate, and other bodily stats is anticipated to revolutionize the market by 2025.

The smart fitness devices market has been segmented based on product into the smartwatch, wristband, smart clothing, smart shoes, bike computers, and others. Based on types, the market has been segmented into head-wear, torso-wear, hand-wear, leg-wear, and bike mount. The hand-wear segment is the biggest segment in terms of size and is expected to dominate the market over the forecast period. This growth may be attributed to the high demand of wristbands and smartwatches. The torso-wear segment is anticipated to experience a notable shift in its growth owing to the rising demand for smart clothing.

The growing awareness and popularity of smart fitness products are encouraging producers to invest in research & development for creating better products. Manufacturers are making massive investments to develop several new products in order to enhance user experience. Researchers are focusing on developing cost-effective and reliable products.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/smart-fitness-devices-market

Further key findings from the report suggest:

The growing demand for smart fitness devices market can be accredited to the increasing demand among individuals for keeping track of various body parameters such as heart rate, sleep, steps taken, calories burned, and others.
The growing penetration of Internet of Things (IoT) and enhanced internet accessibility, which helps to direct digital controls for improved Machine-to-Machine (M2M) communication, have encouraged users to adopt smart fitness devices.
The increase in adoption of wireless technology, sensor technology, miniaturized hardware, cloud services, and smartphone have enabled smart fitness market to emerge as a new promising consumer segment.
The North American region accounted for the largest market share in 2016, which may be attributed to its large consumer base.
Key industry participants include Apple Inc. (U.S.), Fitbit Inc. (U.S.), Garmin Ltd. (Switzerland), Samsung Electronics Co., Ltd. (South Korea), and Xiaomi Inc. (China).

Erythropoietin Drugs Market Size Worth $17.4 Billion By 2025

The global erythropoietin drugs market is expected to reach USD 17.4 billion by 2025, according to a new report by Grand View Research, Inc. Rising incidence of chronic diseases such as CKD and cancer resulting in anemia is a major growth driver of this market.

According to the statistics published by the National Heart, Lung, and Blood Institute of the U.S. Department of Health & Human Services, over 3 million people are affected by anemia every year and this number is expected to increase over the forecast period. This showcases the need for erythropoietin-stimulating agents in the coming years.

Introduction of novel drugs and their cheaper biosimilar formulations with enhanced efficacy and cost-effectiveness is also expected to serve this industry with lucrative opportunities. For instance, development of numerous biosimilars in the European market is expected to gain traction and increase their usage rates, owing to associated benefits such as less time required for approval, cost-efficiency, and enhanced therapeutic effect.

Companies are involved in extensive R&D initiatives for development of innovative molecules and discovering new therapeutic areas for existing drugs. For instance, in April 2016, Sandoz received approval from the European Commission for use of its biosimilar Binocrit in nephrology indications, thereby extending the therapeutic area of its product portfolio.

Moreover, many of the industry players in the U.S., Europe, and Asia Pacific are involved in the development of new biosimilars. For example, Biocon’s subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend their drug discovery and development program in India. This enables Biocon to enhance its erythropoietin drugs portfolio. Expected product approvals in the coming years are anticipated to fuel market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/erythropoietin-epo-drugs-market

Further key findings from the report suggest:

The biologics segment is declining over the forecast period owing to patent expiration of branded biologics and introduction of biosimilars in the market
The patent for Aranesp (darbepoetin-alfa) will expire in 2024 in the U.S. and is expected to provide numerous future growth opportunities for new market entrants
Epoetin-alfa held the largest share of product segment owing to its early introduction in the U.S. market and patent protection
Epoetin-omega and epoetin-zeta are anticipated to exhibit lucrative growth over the forecast period owing to associated benefits such as longer half-life and enhanced therapeutic effects
Use of erythropoietin drugs for treatment of renal diseases held a dominant share as of 2016 owing to the increasing incidence of chronic kidney diseases
The Asia Pacific regional industry for erythropoietin-stimulating agents is expected to witness lucrative CAGR during the forecast period
Industry participants are focusing on the discovery of new therapeutic areas for existing drugs and development of cost-effective biosimilars, thereby increasing R&D activities for the development of erythropoietin drugs.

DevOps Market Size Worth $12.85 Billion by 2025

The global DevOps market size is expected to reach USD 12.85 billion by 2025, according to a new study by Grand View Research, Inc., registering an 18.60% CAGR during the forecast period. Increasing digitization of enterprises to automate business processes, rising adoption of cloud technologies, soaring adoption of agile frameworks, and need for better collaboration between IT teams to enhance operational efficiency will drive market growth.

DevOps tools and solutions address a variety of inefficiencies faced across the software development lifecycle. DevOps help enhance collaborations between development, operations, and quality assurance teams to facilitate continuous integration, testing, and delivery of software. DevOps tools enable enterprises to automate software development and testing lifecycle by standardizing and automating the movement and deployment of code across different environments. These tools enable developers to integrate a continuous feedback loop so that they can shorten response time and continuously release software based on user feedback and usage behavior.

Organizations of all sizes are increasingly deploying DevOps tools to enhance productivity, streamline workflows, reduce time to market, deliver better quality software, and minimize costs associated with software development, delivery, and maintenance. However, issues such as lack of skilled workforce and standardized DevOps tool set or solutions are expected to challenge the industry.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/development-to-operations-devops-market

Further key findings from the report suggest:

North America is expected to account for the largest share during the forecast period, followed by Europe. Key factors contributing to regional growth are rapid adoption of digital services, advanced cloud infrastructure, and presence of major technology players
Asia Pacific emerged as the fastest-growing market, owing to rising presence of advanced infrastructure and increasing penetration of smartphones, smart devices, and digital services in developing countries such China, India, and Japan
The large enterprises segment accounted for over 61.0% of the overall market in 2017. However, the SME segment is expected to demonstrate a high growth rate over the forecast period owing to increasing number of small and medium enterprises across various regions delivering digital services
The IT application segment dominates with a share of over 36.0% in the overall market in 2017, followed by the BFSI segment.Increasing online and mobile transactions, coupled with rising demand of customers for better solutions and services, are expected to drive market growth
Key participants include IBM Corporation; CA Technologies; Cisco Systems, Inc.; Hewlett Packard Enterprise; Chef, Inc.; Puppet Labs, Inc.; Docker, Inc.; Clarizen, Inc.; and Microsoft Corporation.

Blood Collection Market Size Worth $13.99 Billion By 2026

The global blood collection market size is expected to reach a value of USD 13.99 billion by 2026, expanding at a CAGR of 6.6%, according to a new report by Grand View Research, Inc. Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period.

According to the World Health Organization, over 41 million individuals that are equivalent to almost 71% of global deaths were caused due to non-communicable diseases in 2018. Cardiovascular diseases registered the highest mortality rates of over 17.9 million followed by cancer that claimed 9 million deaths and respiratory diseases such as chronic obstructive pulmonary disease & asthma claimed over 3.9 million lives in 2017 globally. These facts are indicative of an increase in the incidence of non-communicable diseases, which is expected to fuel market growth.

An increase in the number of road accidents is anticipated to lead to a rise in demand for blood and its components. According to the National Trauma Institute, trauma injuries account for 30% of lives lost globally. The economic burden due to trauma injuries accounts for nearly USD 671 billion in a year. Statistics from the same source indicate that trauma is the number one cause of death from the age of 1 to 46. These facts are indicative of the rising incidence of trauma injuries that require blood collection products for effective treatment.

The growing rate of novel product launches and investments are anticipated to fuel the market growth during the forecast period. For instance, in August 2019, Velano Vascular announced that the company received an investment of USD 10 million from its strategic investor, Intermountain Healthcare for Velano Vascular’s FDA cleared PIVO needle-free blood collection technology.

PIVO device temporarily attaches itself to a peripheral IV catheter that collects the fresh venous sample. This device uses disposable needle-free that caters to lowered risks, improved quality of care, and increased efficiency. Therefore, the use of such novel technologies to avoid painful blood collection methods is expected to fuel market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/blood-collection-market

Further Key Findings from the Study Suggest:

Blood collection tubes witnessed huge demand owing to its increasing usage in diagnostics and blood sampling, thus, generated largest revenue in the year 2018
Treatment application is anticipated to gain significant market share in the near future owing to rising incidence of chronic diseases
The diagnostics application segment held the largest revenue share in 2018, due to the expanding pool of geriatric population and escalating prevalence of infectious & non-communicable diseases
In 2018, the hospitals segment accounted for the largest share in the market due to an upsurge in the incidence of trauma & accidental cases along with growing number of surgical procedures
North America held the largest share of the blood collection market in the year 2018, which can be attributed to the presence of a highly developed healthcare infrastructure and advanced blood collection products.
Some of the key companies include Abbott Laboratories, NIPRO Medical Corp., Becton, Dickinson and Company, Terumo Corp., Medtronic, Qiagen, and FL MEDICAL s.r.l.

Latin America ERP Software Market Size Worth $2.73 Billion By 2025

The Latin America ERP software market size is expected to reach USD 2.73 billion by 2025, according to a new report conducted by Grand View Research, Inc. ERP applications have helped many large-scale organizations to bring clarity and visibility into their business. With rapidly growing small and medium enterprises (SMEs) and the adoption of evolving technology demand in SMEs is expected to grow over the forecast period. Furthermore, rising awareness among small & medium enterprises (SMEs) and increasing need for business process efficiency and transparency aid the market growth over the forecast period.

SMEs have been facing various barriers to the adoption of this technology because of the expensive and less user-friendly nature of the software. Many SMEs in Brazil, Mexico, Chile, and Peru are still using old IT systems to operate their business. There is a growing need for the adoption of upcoming IT systems to sustain in the competitive market. enterprise resource planning software helps the operation of core business processes including sales & distribution, supply chain management, accounting, financial control, and HR, which is expected to propel demand from various SMEs.

The cloud deployment segment is expected to witness a significant growth rate, due to its growing adoption, although the on-premise deployment segment is anticipated to dominate the market (in terms of size) by 2025. Cloud-based applications reduce IT infrastructure costs leading to the adoption of cloud-based applications among enterprises. The investment in cloud-connected mobile applications has increased as mobile owing to the growing penetration of Bring Your Own Device (BYOD) among the organizations. The vendors are developing cloud-based solutions that can be accessed via mobile platforms such as tablets and smartphones expected to influence the Latin America ERP software market growth further.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/latin-america-enterprise-resource-planning-erp-software-market

Further key findings from the report suggest:

One of the major factors expediting market growth are the evolution of enterprise software and workplace automation industry practices in the Latin America marketplace.
Increasing investment in manufacturing coupled with rising demand for industry dedicated software is expected to propel growth over the forecast period.
Brazil region dominated the marketplace, accounting for the largest global market share (in terms of revenue) in 2016
In Mexico growth is driven by increasing vehicle and parts production particularly in the states of Aguascalientes, Guanajuato, and San Luis Potosi
The key industry participants include IBM (U.S.A.), Oracle (U.S.A.), Microsoft (U.S.A.), SAP SE (Germany), Infor (U.S.A.), and Sage Group Plc (U.K.).

LED Lighting Market Size Worth $127.04 Billion By 2027

The global LED Lighting market size is expected to reach USD 127.04 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 13.4% over the forecast period. The LED lighting offers benefits such as energy efficiency, cost-saving, longer service life, lower heat emission, and nanosecond switching capability, fueling the product demand in the market. Advantage of directional controlled light is anticipated to further drive the demand. Technological advancements and availability of numerous design options for fixtures and lamps due to compact shape and features, such as daylighting, occupancy senor, dim-ability, and timer, are anticipated to positively influence the growth. The energy conservation policy introduced by governments across the world, providing incentives, and attractive rebates for individuals and organizations in commercial and industrial spaces has further contributed to market growth.

LED lighting is widely adopted across commercial and industrial space as the LED lights contribute towards delivering maximum visibility for an appropriate work environment. The introduction of LED in the lighting industry readily became an accepted standard for lighting for commercial and industrial buildings. Moreover, technological advancements such as connected and app-controlled lighting proved to be vital for boosting the market growth. Improvements in lighting technology have led to the emergence of flicker-free LED products, which is appropriate for uninterrupted bright light for application areas such as classrooms, hospitals, and offices, among other spaces. The demand across the residential sector is expected to bolster with the development of smart cities providing lucrative growth opportunities for prominent market players.

The pandemic due to COVID-19 has affected the industries across the world and severely impacted the business functions. The need for a lockdown has adversely impacted the businesses leading to reduced employee strength and forced companies to practice social distancing across countries. The demand for indoor and outdoor general lighting is declining owing to the reduced spending capacity of individuals and budget constrain across industries such as retail, manufacturing, and other businesses as they are incurring losses. The delay in construction projects is another concern for LED lighting vendors, which has led to a decline in the performance for the first quarter of the year 2020. The market is expected to recover post-pandemic and achieve positive revenue growth by the end of 2021.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/led-lighting-market

Further key findings from the report suggest:

LED Lighting is estimated to grow at a CAGR of 13.4% over the forecast period 2020 to 2027. The higher demand for illuminating the commercial and industrial space as per the aesthetics of the rooms for better visibility at an affordable price has driven the market growth over the forecast period.
The lamp segment is anticipated to witness the highest growth of a CAGR of 14.5% over the forecast period. The demand is primarily driven by the residential sector owing to encouraging government policies and initiatives.
The Asia Pacific region is expected to dominate the market during the forecast period is anticipated to grow at a CAGR of 14.6% from 2020 to 2027